People who use drugs (PUD)

Services for women who use drugs or opioid substitution therapy. Practical examples for harm reduction and HIV service organisations

shabnam.abdullayeva_2293 — Tue, 07 May 2024 11:21:26 +0000

Services for women who use drugs or opioid substitution therapy. Practical examples for harm reduction and HIV service organisations shabnam.abdullayeva_2293 Tue, 05/07/2024 - 11:21

This handbook offers concrete suggestions and practical examples of activities for women who use drugs. It can also just serve as inspiration for other types of initiatives and projects. The aim is to increase the uptake of services by women who use drugs in the medium term.
To make these suggestions for specific activities as practical as possible, we have developed them in the form of fact sheets, based on the knowledge and experience of women working in women-specific organisations.
The handbook was initially developed by Deutsche Aidshilfe and translated into English and Russian by AIDS Action Europe.

Year

2024 Deutsche Aidshilfe / AIDS Action Europe

Is the material copyright protected?

Yes

Manual for women work _final ENG.pdf

Injecting drug users (IDUs)

NGOs

People who use drugs (PUD)

Women

Global

Harm reduction

Social issues

Prevention and control of infectious diseases among people who inject drugs

shabnam.abdullayeva_2293 — Mon, 27 Nov 2023 10:29:57 +0000

Prevention and control of infectious diseases among people who inject drugs shabnam.abdullayeva_2293 Mon, 11/27/2023 - 10:29

This joint guidance by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) aims to support policy-makers and public health/social programme planners by providing an evidence base for developing national strategies, policies, and programmes for preventing and controlling infections and infectious diseases among people who inject drugs. It also provides practice considerations and aims to inform the monitoring and evaluation of prevention and control strategies, policies, and programmes.

Report ECDC, EMCDDA

Is the material copyright protected?

I don't know

Guidance-prevention-control-PWID-6-November.pdf

Injecting drug users (IDUs)

People who use drugs (PUD)

Caucasus

Central Europe

Eastern Europe

Northern Europe

Southern Europe

Western Europe

Policy

Prevention

Harm reduction in the context of chemsex: training manual

shabnam.abdullayeva_2293 — Wed, 13 Sep 2023 09:09:48 +0000

Harm reduction in the context of chemsex: training manual shabnam.abdullayeva_2293 Wed, 09/13/2023 - 09:09

Sexualised drug use, i.e. the use of any legal or illegal psychoactive substance before or during sex, is not new. In fact, substances have been used to enhance pleasure and overcome inhibitions in many cultures through the ages. Research from the last few decades has shown that sexualised drug use is more frequent among the LGBTQI+ community than other populations. This can partly be traced back to minority stress, which creates a stronger need to connect, to enhance a sense of identity, to deal with painful emotions and
to form a sense of community.

The manual "Harm reduction in the context of chemsex" is divided in two parts. The first part presents the definition of chemsex, problematic chemsex involvement, harm reduction in the context of chemsex engagement and some core guidelines regarding best practices when delivering services on chemsex. The second part of the manual outlines a training workshop on chemsex and harm reduction.

The aim of this manual is to outline a training course that is as interactive as possible, in order to allow trainees to use their analytical, critical and creative skills.

Training materials

Year

2023 AIDS Action Europe; Poulios, A.

Is the material copyright protected?

I don't know

Manual work 08.09 final for web.pdf

Gay men and other MSM

Injecting drug users (IDUs)

Men having sex with men (MSM)

People who use drugs (PUD)

WHO European region

Harm reduction

Positive prevention

Sexual and reproductive health

Rapid Assessment on Access to PrEP in EU/EEA Countries

shabnam.abdullayeva_2293 — Thu, 01 Dec 2022 09:25:57 +0000

Rapid Assessment on Access to PrEP in EU/EEA Countries shabnam.abdullayeva_2293 Thu, 12/01/2022 - 09:25

The efforts to expand the use of PrEP face challenges worldwide. As such, the
UNAIDS target of 3 million people having access to PrEP by 2020 globally, was not4
met. In Europe, there were 68 089 oral PrEP initiations in 2020.5 According to the
European Centre for Disease Prevention and Control (ECDC), "Greater access to PrEP
and progress in PrEP implementation is needed to reach the SDG of ending the AIDS
epidemic by 2030. To achieve this progress, it would be helpful for countries to gain
a better understanding of the barriers within their country to implementing PrEP
programmes. ”

From August to October 2022, AAE invited its member organisations and partners
based in one of the EU Member States to submit their responses on various
aspects of availability, accessibility, affordability, and acceptability (AAAA) of PrEP
in their national context.

This current report is based on the information provided in the survey and
reflects the practical knowledge on the issue of community-based and –led
service organisations that work with key populations. It includes besides the
main findings of the assessment, country profiles, as well as recommendations
for the European Union and its Member States for urgent steps to be taken to
ensure universal, free and low-threshold access to PrEP.

Report

Year

2022 AIDS Action Europe

Is the material copyright protected?

I don't know

PrEp report final.pdf

Gay men and other MSM

Heterosexuals

Men having sex with men (MSM)

People who use drugs (PUD)

Sex workers

Central Europe

Northern Europe

Southern Europe

Western Europe

Advocacy

Affordability

Inequalities in health

Legislation

Pre-exposure prophylaxis (PrEP)

Sexual and reproductive health

Stigma and discrimination

Universal access

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study

shabnam.abdullayeva_2293 — Thu, 01 Sep 2022 11:37:46 +0000

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study shabnam.abdullayeva_2293 Thu, 09/01/2022 - 11:37

The resurgence of heroin use and the misuse of pharmaceutical opioids are some of the reasons for a worldwide increase in opioid dependence. Opioid Medication Therapies (OMT) have amply demonstrated their efficacy. From a medical point of view, the main objectives of OMT concern medical and social outcomes, centred on risk reduction and the cessation of opioid use. But patient points of view can differ and few studies have explored opioid-dependent patient viewpoints on their OMT. This variable seems important to consider in a patient-centred approach. The aim of our study was to explore points of view of people who use drugs (PWUD) treated with OMT, in a large multicentre sample.

Other

Year

2022 Morgane Guillou Landreat, Antoine Dany, Gaelle Challet Bouju, Edouard-Jules Laforgue, J. Cholet, Juliette Leboucher, Jean Benoit Hardouin, the OPAL Group, Caroline Victorri Vigneau & Marie Grall Bronnec

Is the material copyright protected?

I don't know

Website

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-022-00608-6

s12954-022-00608-6.pdf

Injecting drug users (IDUs)

People who use drugs (PUD)

Global

Harm reduction

Preventing opioid overdose deaths with take-home naloxone

shabnam.abdullayeva_2293 — Thu, 01 Sep 2022 11:27:26 +0000

Preventing opioid overdose deaths with take-home naloxone shabnam.abdullayeva_2293 Thu, 09/01/2022 - 11:27

This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to reverse opioid overdose, naloxone can save lives if administered in time. This comprehensive review looks at opioid overdose and how naloxone counteracts it, and discusses the circumstances of opioid overdose deaths and the use of naloxone in regular clinical practice. As well as documenting the historical development and spread of take-home naloxone programmes in Europe and beyond, the study looks at the practical side of their implementation, including the training of naloxone recipients in how to recognise and respond to an overdose. Although take-home naloxone is supported by the World Health Organization, the report finds that barriers to its access exist in Europe and considers how the availability of the intervention may be expanded.

Year

2022 EMCDDA

Is the material copyright protected?

Yes

Website

https://www.emcdda.europa.eu/publications/insights/take-home-naloxone_en

TDXD15020ENN.pdf

Injecting drug users (IDUs)

NGOs

People who use drugs (PUD)

Central Europe

Northern Europe

Southern Europe

Western Europe

Advocacy

Harm reduction

Human rights

Laws and regulations

Legislation

Social issues

Operational considerations for the provision of the HIV continuum of care for refugees from Ukraine in the EU/EEA

shabnam.abdullayeva_2293 — Tue, 05 Jul 2022 12:16:42 +0000

Operational considerations for the provision of the HIV continuum of care for refugees from Ukraine in the EU/EEA shabnam.abdullayeva_2293 Tue, 07/05/2022 - 12:16

This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA. This document has two aims: firstly, to outline what is known of the Ukrainian HIV epidemic, and secondly, to use the HIV continuum of care as a framework to set out suggestions based on published evidence and expert opinion on the management of the HIV continuum of care, with special consideration for people living with HIV from Ukraine. The document will also address the needs of those at risk of acquiring HIV. The main findings of this document were presented during an ECDC.

Guidelines

Year

2022 European Centre for Disease Prevention and Control

Is the material copyright protected?

I don't know

Website

https://www.ecdc.europa.eu/en/publications-data/operational-considerations-provision-hiv-continuum-care-refugees-ukraine-eueea

Operational-considerations-provision-HIV-care-for-Ukraine-refugees.pdf

(Undocumented) Migrants

Gay men and other MSM

LGBTI

People living with HIV (PLHIV)

People who use drugs (PUD)

Refugees

Central Europe

Eastern Europe

Northern Europe

Southern Europe

Western Europe

Human rights

Inequalities in health

Laws and regulations

Legislation

Migration

Policy

Social issues

Testing and counselling

Treatment

European Drug Report 2022: Trends and Developments

shabnam.abdullayeva_2293 — Tue, 05 Jul 2022 12:02:06 +0000

European Drug Report 2022: Trends and Developments shabnam.abdullayeva_2293 Tue, 07/05/2022 - 12:02

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.

Report

Year

2022 EMCDDA

Is the material copyright protected?

I don't know

EDR_2022_18-ONLINE.pdf

Injecting drug users (IDUs)

People who use drugs (PUD)

Central Europe

Southern Europe

Western Europe

Harm reduction

Social issues

Civil Society Monitoring of Harm Reduction in Europe 2021

shabnam.abdullayeva_2293 — Tue, 05 Jul 2022 11:44:05 +0000

Civil Society Monitoring of Harm Reduction in Europe 2021 shabnam.abdullayeva_2293 Tue, 07/05/2022 - 11:44

Correlation – European Harm Reduction Network launched its Civil Society Monitoring of Harm Reduction in Europe in 2021.

The main aim and purpose of C-EHRN monitoring activities is to improve knowledge and information and complement existing data and monitoring efforts in Europe in specific areas of harm reduction based on the perspective of civil society organisations (CSOs). The data collection helps to assess the implementation of certain drug and health policies at national and local level and supports the advocacy efforts at European and EU Member State level.

Report

Year

2022 Correlation European Harm Reduction Network

Is the material copyright protected?

I don't know

Website

https://www.correlation-net.org/monitoring/

MONITORING-OF-HARM-REDUCTION-IN-EUROPE-2021_web.pdf

Gay men and other MSM

Injecting drug users (IDUs)

LGBTI

Migrants

NGOs

People who use drugs (PUD)

Sex workers

Women

Central Europe

Eastern Europe

Northern Europe

Southern Europe

Western Europe

Advocacy

Co-infections

Harm reduction

Monitoring and Evaluation

Policy

Integration of mental health and HIV interventions — Key considerations

admin — Tue, 10 May 2022 16:13:00 +0000

Integration of mental health and HIV interventions — Key considerations admin Tue, 05/10/2022 - 16:13

This publication is primarily intended for national and local policy-makers; global, regional, country and local programme implementers; organizations working in and providers of health, HIV, mental health and other relevant services; civil society; and community-based and community-led organizations and advocates. It brings together and refers to existing HIV and mental health, psychosocial support and other service provision guidelines, recommendations and tools, including the World Health Organization (WHO) Mental Health Gap Action Programme (mhGAP) mhGAP intervention guide and mhGAP operations manual; WHO, United Nations Office on Drugs and Crime and other guidelines and tools related to substance use; and WHO consolidated guidelines, tools and resources on HIV testing, prevention, treatment and care.

Report

Year

2022 UNAIDS, WHO

Is the material copyright protected?

I don't know

Website

https://www.unaids.org/en/resources/documents/2022/integration-mental-health-hiv-interventions

Ethnic minorities

Gay men and other MSM

Injecting drug users (IDUs)

LGBTI

Men having sex with men (MSM)

Migrants

People who are/were in prisons

People who use drugs (PUD)

Prisoners (ex-)

Sex workers

Global

Advocacy

Inequalities in health

Policy

Prevention

Social issues

Stigma and discrimination

Testing and counselling

Treatment